Sterling Capital Management’s Century Therapeutics IPSC Stock Holding History

Sterling Capital Management’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.16K	Sell	2,431 -53	-2%	-$109	﹤0.01%	2938
2026 Q2	$6.09K	Buy	+2,484	New	+$5.67K	﹤0.01%	2504
2025 Q2	–	Sell	-807	Closed	-$384	–	3323
2025 Q1	$384	Sell	807 -782	-49%	-$588	﹤0.01%	3007
2024 Q4	$1.6K	Buy	1,589 +1,443	+988%	+$1.96K	﹤0.01%	2837
2024 Q3	$250	Buy	+146	New	+$286	﹤0.01%	3077

Other funds holding IPSC

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Parametrica Management Wanchai, Hong Kong $142M AUM 113.92% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Sterling Capital Management's IPSC Position: Q3 2026 in Review

Sterling Capital Management reduced its Century Therapeutics (IPSC) stake by 2.1% in Q3 2026, selling an estimated $109 and leaving 2,431 shares worth $4.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2938.

Sterling Capital Management first reported a position in IPSC in Q3 2024 and has held it in 5 quarters since. The position peaked at $6.09K in Q2 2026. 11 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

Sterling Capital Management held 2,431 shares of Century Therapeutics worth $4.16K as of Q3 2026.
Sterling Capital Management sold 53 Century Therapeutics shares in Q3 2026, an estimated $109.
Century Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2938 holding.
Sterling Capital Management first reported a position in Century Therapeutics in Q3 2024 and has held it in 5 quarters since.
Sterling Capital Management's Century Therapeutics position peaked at $6.09K in Q2 2026.
11 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.